Wednesday, December 2 - The Umstead Hotel

5:45 p.m.Reception
7:15 p.m.Dinner
Recognition of new CEO Roundtable on Cancer members and newly accredited CEO Cancer Gold Standard organizations
Presentation of the Dr. Charles A. Sanders Life Sciences Award

Thursday, December 3 - SAS Executive Briefing Center Building C

7:00 a.m.Breakfast and Registration
Shuttle bus service available from 6:45 a.m. to 8:15 a.m. from The Umstead to the SAS Executive Briefing Center
8:30 a.m.Chairman's Welcome
Christopher A. Viehbacher, Gurnet Point Capital
Chairman, CEO Roundtable on Cancer
8:40 a.m.CEO’s Report
Martin J. Murphy Jr., PhD., DMedSc, FASCO
Chief Executive Officer and Co-Founder, CEO Roundtable on Cancer
8:45 a.m.Nominating Committee Report
Robert A. Ingram, Hatteras Venture Partners
Past Chairman and Co-Founder, CEO Roundtable on Cancer
8:50 a.m. Chairman’s Remarks
Christopher A. Viehbacher
9:00 a.m.Life Sciences Consortium Task Force Report
Mace L. Rothenberg, MD, Pfizer
Co-Chair Life Sciences Consortium Task Force
10:00 a.m.CEO Roundtable Photo and Break
10:30 a.m.CEO Cancer Gold Standard Task Force Report
Fikry W. Isaac, MD, MPH, FACOEM, Johnson & Johnson
Judy O’Hagan, Sanofi US
Co-Chairs, CEO Cancer Gold Standard Task Force
11:10 a.m.CEO Roundtable on Cancer – China
Christopher A. Viehbacher
Martin J. Murphy
11:40 a.m.

CEO's Closing Remarks
Martin J. Murphy, PhD, DMedSc, FASCO

 

Chairman’s Closing Remarks
Christopher A. Viehbacher

12:00 - 1:00 p.m.

Buffet Lunch and Adjournment

Transportation from SAS to the airport available beginning at noon.

 


SAS logo

SAS is a tobacco-free campus and is proud to support the CEO Roundtable on Cancer – XIV.
Video and podcasts will be available post-meeting. Release forms will be provided at the meeting.

 

Back to Top